|
1
|
Davis FG and McCarthy BJ: Current
epidemiological trends and surveillance issues in brain tumors.
Expert Rev Anticancer Ther. 1:395–401. 2001. View Article : Google Scholar
|
|
2
|
Buonerba C, Di Lorenzo G, Marinelli A,
Federico P, Palmieri G, Imbimbo M, Conti P, Peluso G, De Placido S
and Sampson JH: A comprehensive outlook on intracerebral therapy of
malignant gliomas. Crit Rev Oncol Hematol. 80:54–68. 2011.
View Article : Google Scholar
|
|
3
|
Sherman JH, Hoes K, Marcus J, Komotar RJ,
Brennan CW and Gutin PH: Neurosurgery for brain tumors: Update on
recent technical advances. Curr Neurol Neurosci Rep. 11:313–319.
2011. View Article : Google Scholar
|
|
4
|
Castro MG, Candolfi M, Kroeger K, King GD,
Curtin JF, Yagiz K, Mineharu Y, Assi H, Wibowo M, Muhammad Ghulam
AK, et al: Gene therapy and targeted toxins for glioma. Curr Gene
Ther. 11:155–180. 2011. View Article : Google Scholar :
|
|
5
|
Hwang HW and Mendell JT: MicroRNAs in cell
proliferation, cell death, and tumorigenesis. Br J Cancer.
94:776–780. 2006. View Article : Google Scholar :
|
|
6
|
Gabriely G, Wurdinger T, Kesari S, Esau
CC, Burchard J, Linsley PS and Krichevsky AM: MicroRNA 21 promotes
glioma invasion by targeting matrix metalloproteinase regulators.
Mol Cell Biol. 28:5369–5380. 2008. View Article : Google Scholar :
|
|
7
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar
|
|
8
|
Yang L, Li Q, Wang Q, Jiang Z and Zhang L:
Silencing of miRNA-218 promotes migration and invasion of breast
cancer via Slit2-Robo1 pathway. Biomed Pharmacother. 66:535–540.
2012. View Article : Google Scholar
|
|
9
|
Wang H, Li XT, Wu C, Wu ZW, Li YY, Yang
TQ, Chen GL, Xie XS, Huang YL, Du ZW and Zhou YX: miR-132 can
inhibit glioma cells invasion and migration by target MMP16 in
vitro. Onco Targets Ther. 8:3211–3218. 2015.
|
|
10
|
Liu H, Song Z, Liao D, Zhang T, Liu F,
Zheng W, Luo K and Yang L: miR-503 inhibits cell proliferation and
invasion in glioma by targeting L1CAM. Int J Clin Exp Med.
8:18441–18447. 2015.
|
|
11
|
Li Z, Liu YH, Diao HY, Ma J and Yao YL:
miR-661 inhibits glioma cell proliferation, migration and invasion
by targeting hTERT. Biochem Biophys Res Commun. 468:870–876. 2015.
View Article : Google Scholar
|
|
12
|
Han J and Chen Q: miR-16 modulate
temozolomide resistance by regulating BCL-2 in human glioma cells.
Int J Clin Exp Pathol. 8:12698–12707. 2015.
|
|
13
|
Costa PM, Cardoso AL, Custódia C, Cunha P,
de Almeida Pereira L and de Lima Pedroso MC: miRNA-21 silencing
mediated by tumor-targeted nanoparticles combined with sunitinib: A
new multimodal gene therapy approach for glioblastoma. J Control
Release. 207:31–39. 2015. View Article : Google Scholar
|
|
14
|
Song L, Huang Q, Chen K, Liu L, Lin C, Dai
T, Yu C, Wu Z and Li J: miR-218 inhibits the invasive ability of
glioma cells by direct downregulation of IKK-β. Biochem Biophys Res
Commun. 402:135–140. 2010. View Article : Google Scholar
|
|
15
|
Tu Y, Gao X, Li G, Fu H, Cui D, Liu H, Jin
W and Zhang Y: MicroRNA-218 inhibits glioma invasion, migration,
proliferation, and cancer stem-like cell self-renewal by targeting
the polycomb group gene Bmi1. Cancer Res. 73:6046–6055. 2013.
View Article : Google Scholar
|
|
16
|
Jun GJ, Zhong GG and Ming ZS: miR-218
inhibits the proliferation of glioma U87 cells through the
inactivation of the CDK6/cyclin D1/p21 pathway. Oncol Lett.
9:2743–2749. 2015.
|
|
17
|
Liu Y, Yan W, Zhang W, Chen L, You G, Bao
Z, Wang Y, Wang H, Kang C and Jiang T: miR-218 reverses high
invasiveness of glioblastoma cells by targeting the oncogenic
transcription factor LEF1. Oncol Rep. 28:1013–1021. 2012.
View Article : Google Scholar
|
|
18
|
Xia H, Yan Y, Hu M, Wang Y, Wang Y, Dai Y,
Chen J, Di G, Chen X and Jiang X: miR-218 sensitizes glioma cells
to apoptosis and inhibits tumorigenicity by regulating
ECOP-mediated suppression of NF-κB activity. Neuro Oncol.
15:413–422. 2013. View Article : Google Scholar
|
|
19
|
Zhang JM, Sun CY, Yu SZ, Wang Q, An TL, Li
YY, Kong YL and Wen YJ: Relationship between miR-218 and CDK6
expression and their biological impact on glioma cell proliferation
and apoptosis. Zhonghua Bing Li Xue Za Zhi. 40:454–459. 2011.(In
Chinese).
|
|
20
|
Gordon S, Akopyan G, Garban H and Bonavida
B: Transcription factor YY1: Structure, function, and therapeutic
implications in cancer biology. Oncogene. 25:1125–1142. 2006.
View Article : Google Scholar
|
|
21
|
Kashyap V and Bonavida B: Role of YY1 in
the pathogenesis of prostate cancer and correlation with
bioinformatic data sets of gene expression. Genes Cancer. 5:71–83.
2014.
|
|
22
|
Baritaki S, Chatzinikola AM, Vakis AF,
Soulitzis N, Karabetsos DA, Neonakis I, Bonavida B and Spandidos
DA: YY1 Over-expression in human brain gliomas and meningiomas
correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levels. Cancer
Invest. 27:184–192. 2009. View Article : Google Scholar
|
|
23
|
Liao WR, Hsieh RH, Hsu KW, Wu MZ, Tseng
MJ, Mai RT, Lee Wu YH and Yeh TS: The CBF1-independent Notch1
signal pathway activates human c-myc expression partially via
transcription factor YY1. Carcinogenesis. 28:1867–1876. 2007.
View Article : Google Scholar
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Setty M, Helmy K, Khan AA, Silber J, Arvey
A, Neezen F, Agius P, Huse JT, Holland EC and Leslie CS: Inferring
transcriptional and microRNA-mediated regulatory programs in
glioblastoma. Mol Syst Biol. 8:6052012. View Article : Google Scholar :
|
|
26
|
Skalsky RL and Cullen BR: Reduced
expression of brain-enriched microRNAs in glioblastomas permits
targeted regulation of a cell death gene. PLoS One. 6:e242482011.
View Article : Google Scholar :
|
|
27
|
Mathew LK, Skuli N, Mucaj V, Lee SS, Zinn
PO, Sathyan P, Imtiyaz HZ, Zhang Z, Davuluri RV, Rao S, et al:
miR-218 opposes a critical RTK-HIF pathway in mesenchymal
glioblastoma. Proc Natl Acad Sci USA. 111:291–296. 2014. View Article : Google Scholar
|
|
28
|
Sui G, el Affar B and Shi Y, Brignone C,
Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR and Shi Y:
Yin Yang 1 is a negative regulator of p53. Cell. 117:859–872. 2004.
View Article : Google Scholar
|
